Shire offers support to individuals with Multifocal Motor Neuropathy (MMN) by providing educational resources, practical information, and valuable connections for you and your family.

Useful tools and clear information on managing life with MMN.

Knowledge to help you have a meaningful conversation with your treatment team.

Connection with nurses with IVIG treatment experience to give you the knowledge and support to actively help with your healthcare experience.

To enroll in MyIgSource, call 1-855-250-5111 or enroll now

MyIgSource is open to all patients regardless of treatment.

Nurse Advocates

Once enrolled in MyIgSource, you will be contacted by and have ongoing access to a nurse advocate who is experienced with IVIG infusions.

The key benefits are:

  • Individualized, live support
  • Ongoing support to enhance your overall healthcare experience

MyIgSource is open to all patients regardless of treatment.

These helpful resources are available for you to download right now.

MyIgSource Summary: an overview of what to expect from MyIgSource for those who are currently on or starting IVIG treatment for MMN image

MyIgSource Summary

An overview of what to expect from MyIgSource for those who are currently on or starting IVIG treatment for MMN.

Key program benefits include:

  • Disease information
  • Individualized support
  • Educational resources
MMN Overview: An overview of MMN, including information about diagnosis, misdiagnosis, and treatment image

MMN Overview

An overview of MMN, including information about diagnosis, misdiagnosis, and treatment.

 

Electrodiagnostic Testing Summary: Provides an overview of electromyography and nerve conduction studies image

Electrodiagnostic Testing Summary

Provides an overview of electromyography and nerve conduction studies. These studies are one of several tools that your healthcare provider may use to identify the causes and severity of nerve damage.

Download Electrodiagnostic Testing Summary
To enroll in MyIgSource, call 1-855-250-5111

MyIgSource is open to all patients regardless of treatment.

References:

  1. Data on file. Baxter Healthcare Corporation. 2011.
  2. Meuth SG, Kleinschnitz C. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options. Eur Neurol. 2010;63(4):193-204.

Speak with one of our experienced Nurse Advocates.

Call 1-855-250-5111 today!

GAMMAGARD LIQUID

was studied in the
largest clinical
trial in MMN
to date.1
Learn More

MMN affects men nearly

3x

more often than women.2

Learn More
Expand

Please expand for Indication and Detailed Important Safety Information.

Selected Important Safety Information about GAMMAGARD LIQUID
  • GAMMAGARD LIQUID can cause decreased kidney function or kidney failure, blood clots in the heart, brain, lungs or elsewhere in the body. Call your healthcare professional or go to your emergency department right away if you have: Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem. Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot.
  • Do not take GAMMAGARD LIQUID if you have a known history of a severe allergic reaction to IgG or other blood products.